The good, the bad and the ugly - The Federal Budget and the Life Sciences industry
The Federal Budget, released on 13 May 2014, has revealed several changes to the life sciences industry, and biotechnology in particular.
AusBiotech, Australia's Biotechnology Organisation, provides commentary on the possible negative and positive consequences of the Federal Budget.
"Budget sweet for research, bruising for biotech industry" discusses changes to the R&D Tax Incentive, along with key new initiatives introduced: the Medical Research Future Fund (MRFF), the Entrepreneurs' Infrastructure Programme (EIP) and the Manufacturing Transition Grants Programme.
Click here for the full article.
Subscribe via Email